Promaxo was founded by Amit Vohra.

Who are Promaxo's investors?

Promaxo's investors include Angel Physicians Fund, Band of Angels, Frontier Path VC.

How much funding has Promaxo raised?

Promaxo has disclosed $60.9M raised across 4 rounds.

Where is Promaxo headquartered?

Promaxo is headquartered in Oakland, US.

Promaxo

Oakland, US · Delaware corporation · 3 known investors

promaxo.com ↗

Promaxo develops a compact, office-based MRI system designed for point-of-care use, with applications including image-guided prostate interventions. The company operates in the medical imaging and medical device sector.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

Amit VohraFounder

Michael BartholomewExecutive

Dinesh KumarExecutive

Board

Jonathan ChenBoard director

Derek HenneckeinBoard directorVenture Partner at Kineticos Life Sciences

Dushyant ChipalkattyBoard director

Investors · 3

Angel Physicians Fund

Band of AngelsSilicon Valley

Frontier Path VCLondon

Reported raises · per SEC filings

Form D private placements

$60.9M disclosed across 4 rounds · 2017–2024

▶$41.9MraisedJul 2024 · 163 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Amit VohraExecutive Officer, Director
Michael BartholomewExecutive Officer, Director
Jonathan ChenDirector
Derek HenneckeDirector
Dushyant ChipalkattyDirector
Dinesh KumarExecutive Officer

Offering amount: $57.3M
Amount sold: $41.9M
Minimum investment: $1
First sale: Mar 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$4.2MraisedJan 2021 · 4 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Michael BartholomewExecutive Officer, Director
Jonathan ChenDirector
Amit VohraExecutive Officer, Director
Dan McCormickDirector

Offering amount: $5M
Amount sold: $4.2M
Minimum investment: $1
First sale: Dec 2020
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$11MraisedMay 2020 · 69 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Amit VohraExecutive Officer, Director
Dan McCormickDirector
Dushyant ChipalkattyDirector
Michael BartholomewExecutive Officer, Director
Jonathan ChenDirector

Offering amount: $30.6M
Amount sold: $11M
Minimum investment: $1
First sale: May 2020
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$3.8MraisedSep 2017 · 10 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Michael BartholomewExecutive Officer, Director
Amit VohraExecutive Officer, Director
Dushyant ChipalkattyDirector

Offering amount: $7.6M
Amount sold: $3.8M
Minimum investment: $1
First sale: Sep 2017
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

MDxHealth5 shared keywordsmdxhealth develops molecular diagnostic tests for urologic diseases, with a focus on prostate cancer. Its products—Confirm mdx, GPS mdx, and Exo mdx—help physicians assess cancer risk, address false-negative biopsies, and guide treatment decisions for patients.

Cancerresearchuk4 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.

Profound Medical3 shared keywordsProfound Medical develops the MRI-guided TULSA Procedure (TULSA-PRO), an incision-free transurethral ultrasound ablation system for treating prostate tissue in men with conditions such as localized prostate cancer. The device uses real-time MRI temperature monitoring and closed-loop feedback to ablate targeted prostate tissue while aiming to preserve erectile function and urinary continence.

American Cancer Society (ACS)3 shared keywordsThe American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support. It provides information, guidance, caregiver resources, screening guidance, and clinical trial navigation for cancer patients, families, and caregivers, and funds cancer research.

Uclahealth3 shared keywordsUCLA Health is an academic health system providing primary, immediate, and specialty medical care including cancer, neuroscience, transplant, orthopedics, cardiovascular, and children's care. It operates hospitals and clinics and trains medical students, with a network of locations in the Los Angeles area.

Companies competing with Promaxo for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Promaxo do?: Promaxo develops a compact, office-based MRI system designed for point-of-care use, with applications including image-guided prostate interventions. The company operates in the medical imaging and medical device sector.
Who founded Promaxo?: Promaxo was founded by Amit Vohra.
Who are Promaxo's investors?: Promaxo's investors include Angel Physicians Fund, Band of Angels, Frontier Path VC.
How much funding has Promaxo raised?: Promaxo has disclosed $60.9M raised across 4 rounds.
Where is Promaxo headquartered?: Promaxo is headquartered in Oakland, US.